Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicine which was referred to the Minister of Health under the provisions of section 24 (5) of the Act and is set out in the Schedule hereto:
Schedule
Product: Taxotere
Active Ingredient: Docetaxel trihydrate 40mg/mL
Dosage Form: Solution for concentrate for infusion
New Zealand Sponsor: Aventis Pharma Limited
Manufacturers: Aventis Pharma, Dagenham, Essex, United Kingdom
Aventis Principes Actifs Pharmaceutiques, Vitry-sur-Seine, France
Dated this 29th day of October 2004.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).